Cargando…

Public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios

BACKGROUND: During the 2009-2010 A(H1N1) pandemic, many people did not seek care quickly enough, failed to take a full course of antivirals despite being authorised to receive them, and were not vaccinated. Understanding facilitators and barriers to the uptake of vaccination and antiviral medicines...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubinstein, Helena, Marcu, Afrodita, Yardley, Lucy, Michie, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350649/
https://www.ncbi.nlm.nih.gov/pubmed/25884522
http://dx.doi.org/10.1186/s12889-015-1541-8
_version_ 1782360215831707648
author Rubinstein, Helena
Marcu, Afrodita
Yardley, Lucy
Michie, Susan
author_facet Rubinstein, Helena
Marcu, Afrodita
Yardley, Lucy
Michie, Susan
author_sort Rubinstein, Helena
collection PubMed
description BACKGROUND: During the 2009-2010 A(H1N1) pandemic, many people did not seek care quickly enough, failed to take a full course of antivirals despite being authorised to receive them, and were not vaccinated. Understanding facilitators and barriers to the uptake of vaccination and antiviral medicines will help inform campaigns in future pandemic influenza outbreaks. Increasing uptake of vaccines and antiviral medicines may need to address a range of drivers of behaviour. The aim was to identify facilitators of and barriers to being vaccinated and taking antiviral medicines in uncertain and severe pandemic influenza scenarios using a theoretical model of behaviour change, COM-B. METHODS: Focus groups and interviews with 71 members of the public in England who varied in their at-risk status. Participants responded to uncertain and severe scenarios, and to messages giving advice on vaccination and antiviral medicines. Data were thematically analysed using the theoretical framework provided by the COM-B model. RESULTS: Influences on uptake of vaccines and antiviral medicines - capabilities, motivations and opportunities - are part of an inter-related behavioural system and different components influenced each other. An identity of being healthy and immune from infection was invoked to explain feelings of invulnerability and hence a reduced need to be vaccinated, especially during an uncertain scenario. The identity of being a ‘healthy person’ also included beliefs about avoiding medicine and allowing the body to fight disease ‘naturally’. This was given as a reason for using alternative precautionary behaviours to vaccination. This identity could be held by those not at-risk and by those who were clinically at-risk. CONCLUSIONS: Promoters and barriers to being vaccinated and taking antiviral medicines are multi-dimensional and communications to promote uptake are likely to be most effective if they address several components of behaviour. The benefit of using the COM-B model is that it is at the core of an approach that can identify effective strategies for behaviour change and communications for the future. Identity beliefs were salient for decisions about vaccination. Communications should confront identity beliefs about being a ‘healthy person’ who is immune from infection by addressing how vaccination can boost wellbeing and immunity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12889-015-1541-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4350649
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43506492015-03-06 Public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios Rubinstein, Helena Marcu, Afrodita Yardley, Lucy Michie, Susan BMC Public Health Research Article BACKGROUND: During the 2009-2010 A(H1N1) pandemic, many people did not seek care quickly enough, failed to take a full course of antivirals despite being authorised to receive them, and were not vaccinated. Understanding facilitators and barriers to the uptake of vaccination and antiviral medicines will help inform campaigns in future pandemic influenza outbreaks. Increasing uptake of vaccines and antiviral medicines may need to address a range of drivers of behaviour. The aim was to identify facilitators of and barriers to being vaccinated and taking antiviral medicines in uncertain and severe pandemic influenza scenarios using a theoretical model of behaviour change, COM-B. METHODS: Focus groups and interviews with 71 members of the public in England who varied in their at-risk status. Participants responded to uncertain and severe scenarios, and to messages giving advice on vaccination and antiviral medicines. Data were thematically analysed using the theoretical framework provided by the COM-B model. RESULTS: Influences on uptake of vaccines and antiviral medicines - capabilities, motivations and opportunities - are part of an inter-related behavioural system and different components influenced each other. An identity of being healthy and immune from infection was invoked to explain feelings of invulnerability and hence a reduced need to be vaccinated, especially during an uncertain scenario. The identity of being a ‘healthy person’ also included beliefs about avoiding medicine and allowing the body to fight disease ‘naturally’. This was given as a reason for using alternative precautionary behaviours to vaccination. This identity could be held by those not at-risk and by those who were clinically at-risk. CONCLUSIONS: Promoters and barriers to being vaccinated and taking antiviral medicines are multi-dimensional and communications to promote uptake are likely to be most effective if they address several components of behaviour. The benefit of using the COM-B model is that it is at the core of an approach that can identify effective strategies for behaviour change and communications for the future. Identity beliefs were salient for decisions about vaccination. Communications should confront identity beliefs about being a ‘healthy person’ who is immune from infection by addressing how vaccination can boost wellbeing and immunity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12889-015-1541-8) contains supplementary material, which is available to authorized users. BioMed Central 2015-02-27 /pmc/articles/PMC4350649/ /pubmed/25884522 http://dx.doi.org/10.1186/s12889-015-1541-8 Text en © Rubinstein et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Rubinstein, Helena
Marcu, Afrodita
Yardley, Lucy
Michie, Susan
Public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios
title Public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios
title_full Public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios
title_fullStr Public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios
title_full_unstemmed Public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios
title_short Public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios
title_sort public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350649/
https://www.ncbi.nlm.nih.gov/pubmed/25884522
http://dx.doi.org/10.1186/s12889-015-1541-8
work_keys_str_mv AT rubinsteinhelena publicpreferencesforvaccinationandantiviralmedicinesunderdifferentpandemicfluoutbreakscenarios
AT marcuafrodita publicpreferencesforvaccinationandantiviralmedicinesunderdifferentpandemicfluoutbreakscenarios
AT yardleylucy publicpreferencesforvaccinationandantiviralmedicinesunderdifferentpandemicfluoutbreakscenarios
AT michiesusan publicpreferencesforvaccinationandantiviralmedicinesunderdifferentpandemicfluoutbreakscenarios